Pathway Financial Advisers’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-15
Closed -$1.84K 440
2024
Q3
$1.84K Sell
15
-252
-94% -$31K ﹤0.01% 355
2024
Q2
$38K Buy
267
+1
+0.4% +$142 0.01% 246
2024
Q1
$34.2K Buy
266
+15
+6% +$1.93K 0.01% 255
2023
Q4
$25.9K Hold
251
0.01% 278
2023
Q3
$22.8K Buy
+251
New +$22.8K 0.01% 282